About Illumigyn
Illumigyn is a company based in Jerusalem (Israel) founded in 2014. Illumigyn has raised $38 million across 2 funding rounds from investors including Ubicom Holdings and Yozma. Illumigyn operates in a competitive market with competitors including Guided Therapeutics, MobileODT, Mobidiag, Periwinkle Technologies and Zilico, among others.
- Headquarter Jerusalem, Israel
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$38 M (USD)
in 2 rounds
-
Latest Funding Round
$33 M (USD), Series B
Nov 03, 2021
-
Investors
Ubicom Holdings
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Illumigyn
Unlock access to complete
Unlock access to complete
Funding Insights of Illumigyn
Illumigyn has successfully raised a total of $38M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $33 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Illumigyn
Illumigyn has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Ubicom Holdings and Yozma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Provider of IT service suite solutions
|
Locked | Locked | Locked |
Investor details for Illumigyn
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Illumigyn
Investment portfolio details for Illumigyn
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Illumigyn
Detailed financials for Illumigyn
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Illumigyn Comparisons
Peer comparison for Illumigyn
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Illumigyn
Illumigyn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guided Therapeutics, MobileODT, Mobidiag, Periwinkle Technologies and Zilico, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Light-based devices for cervical cancer diagnostics are developed.
|
|
| Locked | Locked | Locked |
Smartphone-based tools for cervical cancer screening are developed.
|
|
| Locked | Locked | Locked |
In vitro diagnostics for infectious diseases are developed and provided.
|
|
| Locked | Locked | Locked |
Developer of device for detecting cervical abnormalities
|
|
| Locked | Locked | Locked |
Real-time cancer diagnostics via Electrical Impedance Spectroscopy are developed.
|
Detailed competitors of Illumigyn
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Illumigyn
Complete news archive for Illumigyn
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Illumigyn
Illumigyn was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Illumigyn is headquartered in Jerusalem, Israel. It is registered at Jerusalem, Jerusalem District, Israel.
Illumigyn is a funded company, having raised a total of $38M across 2 funding rounds to date.
Illumigyn was founded in 2014 in Jerusalem, Israel, within the medical device sector. Focus is placed on developing the Gynescope, a patented imaging colposcope equipped with multispectral illumination for early cervical cancer detection. Operations involve enabling imaging during simultaneous interventional procedures to facilitate clinical outcomes. The device is designed for use in womens health diagnostics and related interventions.
Illumigyn's top competitors include Periwinkle Technologies, Guided Therapeutics and Mobidiag.
Illumigyn has 2 investors. Key investors include Ubicom Holdings, and Yozma.